Royal Bank Of Canada Iridex Corp Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.97 - $3.53 $478 - $857	243 Added 810.0%	273 $0
Q1 2024 Nov 05, 2024	SELL	$2.35 - $3.1 $571 - $753	-243 Reduced 89.01%	30 $0
Q1 2024 May 15, 2024	SELL	$2.35 - $3.1 $291 - $384	-124 Reduced 80.52%	30 $0
Q4 2023 Feb 14, 2024	SELL	$1.9 - $3.28 $140 - $242	-74 Reduced 32.46%	154 $0
Q3 2023 Nov 14, 2023	SELL	$1.33 - $2.54 $31 - $60	-24 Reduced 9.52%	228 $0
Q2 2023 Aug 14, 2023	BUY	$1.76 - $2.43 $443 - $612	252 New	252 $0
Q3 2022 Nov 14, 2022	BUY	$2.41 - $3.41 $98 - $139	41 New	41 $0

3.3M

500

33.5K

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $27.7M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.